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Abstract
Purpose: We evaluated the usefulness of color Doppler
flow imaging to compensate for the inadequate resolu-
tion of the ultrasound (US) monitoring during high-
intensity focused ultrasound (HIFU) for the treatment of
hepatocellular carcinoma (HCC).
Materials and methods: US-guided HIFU ablation
assisted using color Doppler flow imaging was per-
formed in 11 patients with small HCC (<3 lesions,
<3 cm in diameter). The HIFU system (Chongqing
Haifu Tech) was used under US guidance. Color
Doppler sonographic studies were performed using an
HIFU 6150S US imaging unit system and a 2.7-MHz
electronic convex probe.
Results: The color Doppler images were used because of
the influence of multi-reflections and the emergence of
hyperecho. In 1 of the 11 patients, multi-reflections were
responsible for the poor visualization of the tumor. In 10
cases, the tumor was poorly visualized because of the
emergence of a hyperecho. In these cases, the ability to
identify the original tumor location on the monitor by
referencing the color Doppler images of the portal vein
and the hepatic vein was very useful. HIFU treatments
were successfully performed in all 11 patients with the
assistance of color Doppler imaging.
Conclusion: Color Doppler imaging is useful for the
treatment of HCC using HIFU, compensating for the
occasionally poor visualization provided by B-mode
conventional US imaging.
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High-intensity focused ultrasound (HIFU), a noninva-
sive method that can cause complete coagulation
necrosis without requiring the insertion of any instru-
ments [1–3], has been applied for the treatment of several
human neoplasms [4, 5], including small hepatocellular
carcinomas (HCCs) [3, 6–8].
We previously reported that ultrasound (US)-com-
puted tomography (CT) three-dimensional (3D) dual
imaging is useful for the treatment of HCCs using HIFU
by compensating for the occasionally poor visualization
provided by B-mode US [6]. The reason for the poor
visualization during HIFU treatment is thought to be
that HIFU machines have been designed with the
assumption that the US probe will not touch the skin to
protect the US probe from the HIFU power during
HIFU sonication and the presence of degassed water
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between the skin and the US probe, consequently, multi-
reflections can influence the image quality [6]. Another
reason for the poor visualization of HCCs during HIFU
treatment is that hyperechos caused by the sonications
[9, 10] can obscure the original tumor contour.
The color Doppler method is a blood ﬂow display
method using the Doppler phenomenon in ultrasonog-
raphy [11]. This technique using ultrasonic waves is
useful because the direction and velocity, flow rate, and
waveform of the blood flow signal can be reliably
examined in vivo noninvasively under physiological
conditions. This technique was introduced clinically to
evaluate the blood flow pattern within tumors during the
latter half of the 1980s [12]. Because both the tumor
image and the blood flow image can be displayed on a
single sonogram using color Doppler flow imaging,
information that can otherwise be gained using sonog-
raphy, hepatic arteriography, hepatic venography, and
portography can be obtained simultaneously. Color
Doppler sonography can show the blood flow and local
hemodynamics in the hepatic vascular system and can be
used to evaluate portosystemic shunts [13] and portal
vein thrombosis [14]. Color Doppler flow imaging is a
diagnostic imaging support system that can provide the
location of the tumor in relation to the vessels on the
monitor. The purpose of the present study was to eval-
uate the usefulness of color Doppler flow imaging in
compensating for the poor visualization of B-mode US
on the HIFU monitor during HIFU treatment for HCC.
Materials and methods
Patients
Between July 2007 and October 2008, 26 patients with
HCC were treated using HIFU; the treatments in 11 of
these patients (7 men, 4 women; mean age, 73.2 years; age
range, 65–80 years) were assisted using color Doppler
imaging (Table 1). The maximum diameter of the tumors
measured on sonography ranged from 10 to 26 mm
(mean, 16.5 mm; SD, 4.5 mm). All the patients had
Child–Pugh classification A or B liver cirrhosis, a pro-
thrombin time ratio greater than 50%, and a platelet count
greater than 50,000/mm3. In one patient, the HCC diag-
nosis was confirmed using a percutaneous needle biopsy.
The remaining 10 patients were diagnosed as having HCC
based on imaging findings (newly presenting tumor on
follow-up ultrasonography in patients with chronic liver
disease and characteristic enhancement pattern on con-
trast-enhanced, multiphase helical CT, contrast-enhanced
MRI, or contrast-enhanced US). All 11 patients had liver
cirrhosis as a result of hepatitis C. At the time of HIFU,
the patients were classified as having Child–Pugh classi-
fication A (n = 10) or B (n = 1) cirrhosis. Transcatheter
arterial chemoembolization (TACE), percutaneous etha-
nol injection (PEI), and rib resection were not performed
prior to HIFU treatment. Prior to treatment, the patient’s
skin was shaved and degassed using a suction pump. An
epidural anesthesia was performed during the procedure.
Our hospital ethics committee approved this study, and
each patient signed an informed consent form at the time
of enrollment.
Ultrasound therapy system
Sonications were performed using a clinical US-guided
ultrasound surgery system. The Tumor Therapy System
(Model AC 0501; Chongqing Haifu Tech Co., Ltd,
Chongqing, China) used in this study was guided using
real-time ultrasonographic imaging [3]. An HIFU 6150S
US imaging unit was installed on the HIFU system to
obtain real-time US imaging during HIFU ablation. A
2–5 MHz imaging probe was located at the center of the
HIFU transducer and was mounted in a reservoir of
degassed water [3]. Therapeutic US energy was produced
using a piezoelectric ceramic transducer with a diameter
of 20 cm, focus length of 15 cm, and an operating fre-
quency of 1.0 MHz [3]. The focal lesion was ellipsoid,
with dimensions of 9.8 mm along the beam axis and
1.3 mm in the transverse direction. The targeted tissue
was exposed to acoustic focal peak intensities of 5000
and 15,000 W cm-2. A calibrated polyvinylidene
difluoride membrane hydrophone with spot diameter
0.5 mm (Shanghai Jiao Tong University, Shanghai,
China) was used to map the acoustic pressure field of the
focused transducer at peak intensities from 200 to
300 W cm-2. After the induction of suitable anesthesia,
the patient was carefully positioned either prone or on
his or her right side so that the skin overlying the lesion
to be treated could be easily placed in contact with the
degassed water. We checked for pain and complications,
and then the US power was increased gradually until a
power of 300–450 W was reached. The time for one
sonication was 5 s. During the focused US ablation, the
real-time US images obtained before and after each
exposure were immediately compared to determine
Table 1. Baseline clinical characteristics of the patients with HCC
(n = 11)
Characteristics
Number of patients 11
Sex (male/female) 7/4
Age 73.2 ± 4.5 (65–80)
Alcohol/HCV/HBsAg 0/11/0
Child A/B/C 10/1/0
Diameter (mm) 16.5 ± 4.5 (10–26)
Table 2. Reasons for use of color Doppler images during HIFU
treatment
Reason for color Doppler use
Multi-reflection 1
Emergence of hyperecho 10
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whether the hyperechos, indicating the extent of coagu-
lation necrosis, had covered the desired treatment area
[15]. Patients were trained to hold their breath at the
point at which their entire tumor became visible when
the tumor was located between the ribs or just below the
diaphragm.
Color Doppler imaging
Color Doppler sonographic studies were performed
using an HIFU 6150S US imaging unit system and a 2.7-
MHz electronic convex probe. On-screen, real-time
B-mode, color Doppler imaging, and spectral analysis
were simultaneously displayed. In this study, we set that
the red indicated ﬂow toward the transducer, and the
blue indicated ﬂow away from the transducer. A low wall
ﬁlter function and a pulse-repetition frequency of
1220 Hz were used to detect tiny vascular structures. If
necessary, the pulse-repetition frequency was increased
once high-velocity arterial ﬂow was detected. The color
gain was adjusted during the examination by selecting
the highest value at which the color images were still
unaffected by the artifacts. The color signal was used as a
guide to obtain the Doppler spectrum. The sample vol-
ume used for the spectral analysis was 2–4 mm.
Assessment of treatment efﬁcacy and follow-up
Dynamic CT scans (Aquilion TSX-101A; Toshiba
Medical Systems Corp., Tochigi, Japan) with a section
thickness of 5 mm or Dynamic MRI scans (Signa HDX
3.0T system; GE Healthcare, Milwaukee, WI) with gra-
dient-echo (GRE) sequences and T1 fat saturation (TR/
TE, 4.8/1.9; ﬂip angle, 12; matrix size, 320 9 192; sec-
tion thickness, 4 mm; intersection gap, 0–2 mm; one
acquisition) with the bolus injection of a 0.025 mmol/kg
dose of gadolinium-ethoxybenzyl-diethylenetriamine
pentaacetic acid (d-EOB-DTPA) (Primovist; Bayer
Schering Pharma) body weight were performed. Assess-
ments using contrast-enhanced (0.2 mL of Sonazoid
suspension; Daiichi Sankyo, Tokyo, Japan) ultrasonog-
raphy (LOGIQ 7; GE Healthcare, Milwaukee) were
performed in all the patients when the hyperecho covered
the original tumor and at 1 week after the HIFU pro-
cedure. A convex volume 4D3C-L probe (GE Health-
care) was used. All the patients received an intravenous
bolus injection of 0.2 mL of Sonazoid via a 24-gage
cannula into a forearm vein, followed by 2 mL of a 5%
glucose solution and the subsequent infusion of a 5%
glucose solution at 10 mL/min. A coded harmonic angio
(CHA) mode with a high mechanical index (0.5–0.9) at
8–13 frames per second was selected for the contrast-
enhanced 3D US procedure. The focus point was set
beneath the tumor [3]. Complete ablation based on the
contrast-enhanced ultrasonography findings was defined
as a perfusion defect with no enhancement and no tumor
vessels during both the early vascular phase and the post
vascular phase [16].
Results
Table 2 summarizes the reasons why the color Doppler
images were used. The reasons for the use of the color
Doppler images included the influence of multi-reflec-
tions and the emergence of a hyperecho. In 1 of the 11
patients, multi-reflections were responsible for the poor
visualization of the tumor. In 10 cases, the tumor was
poorly visualized because of the emergence of a hyper-
echo. In these cases, knowing the original tumor location
on the monitor by referencing the color Doppler images
of the portal vein and the hepatic vein was very useful.
Finally, HIFU treatment assisted by color Doppler
imaging was successfully performed in all the patients.
Representative cases of color Doppler imaging in
patients with HCC are presented in Figs. 1 and 2. The
tumor on the monitor ultrasonogram was clearly visible
because the US probe was located near the surface of the
skin and no multi-reflections were present (Fig. 1A). The
US probe must be pulled down into the inner hole of the
transducer to set the focus of the sonication for the
tumor to protect the US probe; as a result, multi-reflec-
tions between the US probe and the skin surface
emerged, and the tumor on the monitor ultrasonogram
was not clearly visible. By transferring the color Doppler
image data, the location of the original tumor was
identified on the HIFU monitor (Fig. 1B). After the
HIFU treatment, the tumor enhancement disappeared
(Fig. 1C, D), indicating a successful treatment. Fig-
ure 2A shows the US monitor with the color Doppler US
image of the tumor before the HIFU treatment, showing
the tumor to be located on the posterior surface of the
liver (segment 2). During the HIFU treatment, this tu-
mor was not clearly depicted on the monitor because of
the emergence of a hyperecho after sonication (Fig. 2B).
By transferring the color Doppler image data, the loca-
tion of the tumor was identified on the HIFU monitor
(Fig. 2B). The tumor enhancement disappeared after
treatment, and the ablated area after HIFU ablation was
thought to be sufficiently wide enough to encompass an
adequate safety margin (Fig. 2C, D).
Discussion
In the present study, we used the color Doppler image as
an indicator to identify the location of the original tumor
because of the presence of artifacts and hyperechos
caused by microbubbles that formed during the HIFU
treatment.
The B-mode conventional sonography that is used to
monitor the HCC during HIFU treatment is sometimes
inadequate because of artifacts. We reported that US-CT
3D dual imaging is useful for planning of the HIFU
treatment and detecting the tumor, compensating for the
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occasionally poor visualization provided by the US
monitor [6]. The poor visualization using the HIFU
monitor is caused by the presence of multi-reflections
and/or the emergence of hyperechos during HIFU
treatment. The US monitor of the presently used HIFU
machine is designed with the assumption that the US
probe will not touch the skin, and tumor detection can
worsen because the US probe is protected from the
HIFU power when it is moved downward, so that tu-
mors located deep within the liver are easily influenced
by multi-reflections [6]. Therefore, artifacts cause by the
multi-reflections are inevitable; however, the tumor
location can be identified in such cases using color
Doppler imaging.
Another reason for the poor visualization of HCC
during HIFU treatment is that hyperecho caused by the
sonications can obscure the original tumor contour [9]. A
hyperecho is considered to indicate tissue necrosis and
has been used to judge complete ablation [10]. Wang
et al. [17] evaluated the relationship between the volume
Fig. 1. A The tumor located in segment 3 (arrows) on the
monitor ultrasonogram is clearly visible because the US probe
was located near the surface of the skin and there were no
multi-reflections. The flow of the portal vein is shown blue
signal (arrowhead) and the branch of this portal vein is shown
red signal (thick arrow) before sonication. B The US probe
was moved downward to focus on the tumor to protect the US
probe; as a result, the tumor (arrows) on the monitor ultra-
sonogram was not clearly visible. The flow of the portal vein is
shown blue signal (arrow head) and the branch of this portal
vein is shown red signal (thick arrow) after sonication. By
transferring relationship between the color Doppler image
data and the original tumor location, the tumor was recog-
nized on the HIFU monitor. C Contrast-enhanced US imaging
before (arrows). D Just after HIFU (arrows). Just after HIFU,
the tumor enhancement disappeared.
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of the ablation and the depth using bovine liver tissue. In
the US-guided HIFU therapy system used in the present
study, a hyperecho resulting from bubble activity gen-
erated during HIFU exposure was regarded as a sign that
the treated lesion had been completely coagulated, since
the system itself was unable to perform thermometry of
the ablated area [15]. The presence of cavitation in the
US field was also correlated with a rapid rise in tem-
perature both in vitro [18] and in vivo [19]. The ablated
area and the extension of the hyerecho were not always
the same, and the original tumor contour was obscure by
the hyperecho [6]. The appearance of microbubbles,
indicating that the temperature of the area is above the
boiling point, was also observed using US during
radiofrequency ablation (RFA), making it difficult to
identify the location of the original tumor. The evalua-
tion of the ablated area and the hyperecho after RFA
was reportedly difficult, and contrast-enhanced ultraso-
nography was useful for such evaluations [20]. We think
that contrast-enhanced ultrasonography may be useful
Fig. 2. A The tumor is located in the posterior surface of the
liver (segment 2) (arrows) by color Doppler US image before
sonication. The flow of the portal vein (thick arrow) and the
hepatic vein (arrowhead) are shown as blue signal before
sonication. B The resulting hyper-echogenic changes
obscured part of the contours of the original tumor (arrows).
The flow of the portal vein (thick arrow) and the hepatic vein
(arrowhead) are shown as blue signal after sonication. Thick
arrow and arrowhead indicate the same flow before and after
sonication, so, the location of the tumor was recognized after
HIFU sonication from the relationship between the color
Doppler flow imaging and the original tumor. C The tumor
enhancement before the HIFU treatment (arrows) disap-
peared just after the treatment on contrast-enhanced US
imaging. D The ablated area (arrows) is wide enough with an
adequate safety margin.
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for determining the relationship between the ablated area
and the hyperecho at the end of HIFU treatment, but
color Doppler may be superior when the location must
be confirmed for each sonication during the HIFU
treatment, since the patient does not need to be moved.
As a result, we were able to clarify the locations of
tumors that had been obscured by artifacts based on the
relationship between the original tumor and the color
Doppler image.
In this study, the utility of color Doppler imaging
during HIFU treatment for HCCs was evaluated, and
the assistance provided by this modality was found to be
useful.
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